Synopsis
Synopsis
0
USDMF
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1 Alpha-hydroxycholecalciferol
2. 1 Alpha-hydroxyvitamin D3
3. 1-alpha-oxycholecalciferol
4. 1-hydroxycholecalciferol
5. 1-hydroxycholecalciferol, (1alpha,3alpha-(5z,7e))-isomer
6. 1-hydroxycholecalciferol, (1beta)-(5z)-isomer
7. 1-hydroxycholecalciferol, (1beta,3beta-(5e,7e))-isomer
8. 1-hydroxycholecalciferol, Aluminum Salt
9. 1alpha-ohd3
10. Alfad
11. Alphacalcidol
12. Bondiol
13. Eenalfadrie
14. Einsalpha
15. Etalpha
16. Oksidevit
17. One-alpha
18. Un-alfa
1. 1-hydroxycholecalciferol
2. Alphacalcidol
3. 41294-56-8
4. 1alpha-hydroxyvitamin D3
5. Alfarol
6. Bondiol
7. Einsalpha
8. Etalpha
9. Oxydevit
10. 1-hydroxyvitamin D3
11. 1alpha-hydroxycholecalciferol
12. Alsiodol
13. Alpha-calcidol
14. One-alpha
15. Alfacalcidolum
16. Un-alpha
17. 1alpha-hydroxy-vitamin D3
18. Vitamin D3, 1alpha-hydroxy-
19. Alpharol
20. Tevabone
21. Un Alpha
22. Un Alfa
23. .alpha.-calcidol
24. 1.alpha.-hydroxyvitamin D3
25. 1-alpha-vitamin D
26. 1.alpha.(oh)d3
27. 1-alpha-hydroxy-vitamin D3
28. 1.alpha-hydroxycholecalciferol
29. 1.alpha.-hydroxycholecalciferol
30. (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
31. Chebi:31186
32. (5z,7e)-9,10-seco-5,7,10(19)-cholestatrien-1alpha,3beta-diol
33. Alpha D3
34. 1
35. A-hydroxy-5,6-trans-vitamin D3
36. Urq2517572
37. (1r,3s)-5-[2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
38. 1alpha-hydroxyvitamin D3 / 1alpha-hydroxycholecalciferol
39. 1alpha-oh-d3
40. 9,10-secocholesta-5,7,10(19)-triene-1alpha,3beta-diol
41. Sinovul
42. (5z,7e)-(1s,3r)-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol
43. Alpha-d3
44. Alpha D 3
45. 1 Alpha-hydroxyvitamin D3
46. Alfacalcidolum [inn-latin]
47. Alfacalcidiol
48. Onealfa
49. Diseon
50. 1-alpha-hydroxycholecalciferol
51. Alfacalcidol [inn:ban:jan]
52. Ccris 3341
53. Unii-urq2517572
54. Alsiodol (tn)
55. Einecs 255-297-1
56. Eb 644
57. 1a-hydroxycholecalciferol, Alfacalcidol
58. 1-hydroxy Vitamin D3
59. 1-alpha-hydroxyvitamin D
60. Alfacalcidol (jan/inn)
61. Udpgatriammoniumsalt
62. Alfacalcidol [inn]
63. Alfacalcidol [jan]
64. 1-alpha-hydroxyvitamin D3
65. Schembl3063
66. Alfacalcidol [mart.]
67. Alfacalcidol [who-dd]
68. Chembl1601669
69. Dtxsid0022569
70. Chebi:94779
71. Alfacalcidol [ep Monograph]
72. 1(alpha)-hydroxyvitamin D3
73. Cs-m0939
74. Ex-a4432
75. Lmst03020231
76. Zinc12484965
77. Akos017343040
78. Cs-0389
79. Db01436
80. Lp-0030
81. 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, (1.alpha.,3.beta.,5z,7e)-
82. Hy-10003
83. Alfacalcidol 100 Microg/ml In Acetonitrile
84. 1.alpha.-hydroxycholecalciferol [mi]
85. 1alpha-hydroxyvitamin D3, >=97.0% (hplc)
86. D01518
87. Q155883
88. Q-200608
89. 9,10-secocholesta-,7,10(19)-triene-1alpha,3beta-diol
90. (1s,3r,5z,7e)-9,10-secocholesta-5,7,10-triene-1,3-diol
91. Alfacalcidol, European Pharmacopoeia (ep) Reference Standard
92. (1alpha,3beta,5z,7e)-secocholesta-5,7,10(19)-triene-1,3-diol
93. (5z,7e)-9,10-secocholesta-5,7,10(19)-triene-1alpha,3beta-diol
94. (1?,3?,5z,7e)-9,10-secocholesta-5,7,10(19)-triene-1,3-diol
95. 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, (1alpha,3beta,5z,7e)-
96. (1alpha,3beta,5z,7e)-9,10-secocholesta-5,7,10(19)-triene-1,3-diol
97. (5z,7e)-9,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.-diol
98. 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, (1-alpha,3-beta,5z,7e)-
99. Alfacalcidol For System Suitability, European Pharmacopoeia (ep) Reference Standard
100. (1r,3s,z)-5-((e)-2-((1r,3as,7ar)-7a-methyl-1-((r)-6-methylheptan-2-yl)hexahydro-1h-inden-4(2h)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
101. 1,3-cyclohexanediol, 5-((2e)-2-((1r,3as,7ar)-1-((1r)-1,5-dimethylhexyl)octahydro-7a-methyl-4h-inden-4-ylidene)ethylidene)-4-methylene-, (1r,3r)-
102. M9b
Molecular Weight | 400.6 g/mol |
---|---|
Molecular Formula | C27H44O2 |
XLogP3 | 6.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 400.334130642 g/mol |
Monoisotopic Mass | 400.334130642 g/mol |
Topological Polar Surface Area | 40.5 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 643 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Alfacalcidol is indicated in adult patients with chronic renal failure for the management of hypocalcemia, secondary hyperparathyroidism, or osteodystrophy. Alfacalcidol is indicated in the management of nutritional and malabsorptive rickets and osteomalacia, vitamin D-dependent rickets and osteomalacia, and hypophosphataemic vitamin D resistant rickets and osteomalacia.
FDA Label
Alfacalcidol works to increase serum levels of calcium by stimulating intestinal calcium absorption, reabsorption of calcium from bone, and possibly the renal reabsorption of calcium. It also modestly promotes intestinal phosphorus absorption. In patients with renal failure, alfacalcidol increased intestinal calcium and phosphorus absorption in a dose-related manner. This increase in calcium and phosphorus levels occurs within three days following drug administration: this effect was reversed within three days of drug discontinuation. In patients with chronic renal failure, serum calcium levels were elevated while parathyroid hormone and alkaline phosphatase levels returned to normal levels within five days following alfacalcidol administration. Since alfacalcidol suppresses parathyroid hormone, a reduction in parathyroid hormone levels is achieved more rapidly in patients on intermittent intravenous therapy, with significant reductions occurring within three months of therapy. In patients receiving daily oral therapy of alfacalcidol, the time it takes alfacalcidol to normalize plasma calcium levels may be up to several months, possibly reflecting calcium being utilized for bone mineralization. In patients with nutritional osteomalacia, alfacalcidol increased calcium absorption with six hours of oral administration and the effects peaked at 24 hours.
Bone Density Conservation Agents
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)
A - Alimentary tract and metabolism
A11 - Vitamins
A11C - Vitamin a and d, incl. combinations of the two
A11CC - Vitamin d and analogues
A11CC03 - Alfacalcidol
Absorption
Alfacalcidol is absorbed passively and almost completely in the small intestine.
Alfacalcidol is rapidly converted in the liver to 1,25-dihydroxyvitamin D, which is essentially the metabolite of vitamin D that regulates calcium and phosphate metabolism. Alfacalcidol is further metabolized to other polar inactive metabolites, excreted primarily through the bile.
The half-life of alfacalcidol ranges from three to four hours.
In conditions like chronic renal failure, renal bone disease, hypoparathyroidism, and vitamin D dependent rickets, the kidneys' capacity for 1-hydroxylation is impaired, leading to reduced production of endogenous 1,25-dihydroxyvitamin D and aberrated mineral metabolism. As an active and potent analog of vitamin D, alfacalcidol works to restore the functions and activities of endogenous 1,25-dihydroxyvitamin D.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2000-100 - Rev 07
Issue Date : 2025-01-17
Type : Chemical
Substance Number : 1286
Status : Valid
ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & novel modalities with ICH-grade quality.
Registrant Name : Hoosung Bio Co., Ltd.
Registration Date : 2025-02-18
Registration Number : 20250218-211-J-1747
Manufacturer Name : DK Pharma CHEM PVT.LTD.
Manufacturer Address : F-32/W-7, MIDC, BADLAPUR, DIST-THANE, BADLAPUR- 421503, Dist-THANE, ZONE6, India
Certificate Number : R1-CEP 2007-286 - Rev 02
Issue Date : 2020-02-18
Type : Chemical and TSE
Substance Number : 1286
Status : Valid
Certificate Number : R1-CEP 2000-399 - Rev 05
Issue Date : 2020-09-22
Type : Chemical and TSE
Substance Number : 1286
Status : Valid
Certificate Number : CEP 2024-060 - Rev 00
Issue Date : 2024-12-19
Type : Chemical and TSE
Substance Number : 1286
Status : Valid
Registration Number : 302MF10045
Registrant's Address : 36 Hoping Street, Louchu, Taoyuan 33842, Taiwan
Initial Date of Registration : 2020-04-14
Latest Date of Registration : 2020-04-14
Registration Number : 217MF11108
Registrant's Address : 25 Kanda Nishikicho 1-chome, Chiyoda-ku, Tokyo
Initial Date of Registration : 2005-12-05
Latest Date of Registration : 2006-11-06
Alfacalcidol (for manufacturing only)
Registration Number : 222MF10194
Registrant's Address : 1410 Takada, Kashiwa City, Chiba Prefecture
Initial Date of Registration : 2010-07-09
Latest Date of Registration : 2021-01-20
Registration Number : 218MF10176
Registrant's Address : 2-1 Kasumigaseki 3-chome, Chiyoda-ku, Tokyo
Initial Date of Registration : 2006-02-08
Latest Date of Registration : 2010-03-09
Registrant Name : Sungjin Exim Co., Ltd.
Registration Date : 2023-03-23
Registration Number : 20230323-211-J-1462
Manufacturer Name : CARBOGEN AMCIS BV
Manufacturer Address : Nieuweweg 2a, Veenendaal, 3901 BE, Netherlands
Registrant Name : Hoosung Bio Co., Ltd.
Registration Date : 2025-02-18
Registration Number : 20250218-211-J-1747
Manufacturer Name : DK Pharma CHEM PVT.LTD.
Manufacturer Address : F-32/W-7, MIDC, BADLAPUR, DIST-THANE, BADLAPUR- 421503, Dist-THANE, ZONE6, India
Registrant Name : Eltek Pharmachem Co., Ltd.
Registration Date : 2025-06-02
Registration Number : 20250602-211-J-1904
Manufacturer Name : Nanjing Heron Pharmaceutical...
Manufacturer Address : No. 122 Huakang Road, Jiangbei New Area, Nanjing 211800, China
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & novel modalities with ICH-grade quality.
About the Company : ChemExpress is a leading CRO and CDMO partner supporting pharmaceutical and biotech companies worldwide. We specialize in small molecules, biologics, and next-gen modalities includ...
About the Company : Arena Pharmaceuticals, established in 2001 and based in Central England, specializes in sourcing, procuring, storing, and supplying high-quality Active Pharmaceutical Ingredient...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : With 33 years of CONSISTENCY, CREDIBILITY & CONTINUITY, D K Pharma has established its presence in the Global Market for Manufacturing Bulk Drugs, Speciality Fine Chemicals and Adv...
About the Company : Formosa Laboratories Inc. founded in Taiwan since 1995 started with API business and has been serving customers worldwide. As an established API manufacturer receiving GMP inspecti...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
Alfacalcidol - reference spectrum
CAS Number : n/a
Quantity Per Vial : n/a
Sale Unit : 1
Order Code : A0325451
Batch No : 1
Price (€) : 79
Storage :
Alfacalcidol for system suitability
CAS Number : 41294-56-8
Quantity Per Vial : 2.5 mg
Sale Unit : 1
Order Code : Y0001601
Batch No : 1
Price (€) : 79
Storage : -20°C ± 5°C
CAS Number : 41294-56-8
Quantity Per Vial : 5 mg
Sale Unit : 1
Order Code : A0325450
Batch No : 9
Price (€) : 300
Storage : -20°C ± 5°C
ABOUT THIS PAGE
29
PharmaCompass offers a list of Alfacalcidol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alfacalcidol manufacturer or Alfacalcidol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alfacalcidol manufacturer or Alfacalcidol supplier.
PharmaCompass also assists you with knowing the Alfacalcidol API Price utilized in the formulation of products. Alfacalcidol API Price is not always fixed or binding as the Alfacalcidol Price is obtained through a variety of data sources. The Alfacalcidol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A alphacalcidol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of alphacalcidol, including repackagers and relabelers. The FDA regulates alphacalcidol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. alphacalcidol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of alphacalcidol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A alphacalcidol supplier is an individual or a company that provides alphacalcidol active pharmaceutical ingredient (API) or alphacalcidol finished formulations upon request. The alphacalcidol suppliers may include alphacalcidol API manufacturers, exporters, distributors and traders.
click here to find a list of alphacalcidol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The alphacalcidol Drug Master File in Japan (alphacalcidol JDMF) empowers alphacalcidol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the alphacalcidol JDMF during the approval evaluation for pharmaceutical products. At the time of alphacalcidol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of alphacalcidol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a alphacalcidol Drug Master File in Korea (alphacalcidol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of alphacalcidol. The MFDS reviews the alphacalcidol KDMF as part of the drug registration process and uses the information provided in the alphacalcidol KDMF to evaluate the safety and efficacy of the drug.
After submitting a alphacalcidol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their alphacalcidol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of alphacalcidol suppliers with KDMF on PharmaCompass.
A alphacalcidol CEP of the European Pharmacopoeia monograph is often referred to as a alphacalcidol Certificate of Suitability (COS). The purpose of a alphacalcidol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of alphacalcidol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of alphacalcidol to their clients by showing that a alphacalcidol CEP has been issued for it. The manufacturer submits a alphacalcidol CEP (COS) as part of the market authorization procedure, and it takes on the role of a alphacalcidol CEP holder for the record. Additionally, the data presented in the alphacalcidol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the alphacalcidol DMF.
A alphacalcidol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. alphacalcidol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of alphacalcidol suppliers with CEP (COS) on PharmaCompass.
alphacalcidol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of alphacalcidol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right alphacalcidol GMP manufacturer or alphacalcidol GMP API supplier for your needs.
A alphacalcidol CoA (Certificate of Analysis) is a formal document that attests to alphacalcidol's compliance with alphacalcidol specifications and serves as a tool for batch-level quality control.
alphacalcidol CoA mostly includes findings from lab analyses of a specific batch. For each alphacalcidol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
alphacalcidol may be tested according to a variety of international standards, such as European Pharmacopoeia (alphacalcidol EP), alphacalcidol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (alphacalcidol USP).